Skip to main content

Month: April 2020

La Fondation TELUS pour un futur meilleur verse 250 000 $ pour soutenir les sans-abri et les citoyens marginalisés pour les aider à faire face à la pandémie de COVID-19

VANCOUVER, Colombie-Britannique, 24 avr. 2020 (GLOBE NEWSWIRE) — La Fondation TELUS pour un futur meilleur a annoncé aujourd’hui un don de 250 000 $ en vue d’aider des organismes de soins de santé communautaires à intervenir auprès des sans-abri et des citoyens marginalisés à l’échelle du Canada en réponse à la pandémie de COVID-19. Ce financement amplifiera les efforts déployés afin de fournir une multitude de services, notamment des tests de dépistage de la COVID-19, un service de triage et des abris temporaires à des fins d’isolement. De plus, il permettra d’acheter de l’équipement de protection individuelle et des articles de nettoyage afin d’offrir un environnement propre et sécuritaire aux patients et aux cliniciens. Puisque la propagation de la COVID-19 se poursuit et qu’il y a plus de 235 000 sans-abri au Canada chaque année,...

Continue reading

Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer

AUSTIN, Texas, April 24, 2020 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that Aaron Schuchart will be joining the company as Chief Business Officer starting on May 6, 2020. In this role, Mr. Schuchart will coordinate with Lumos Pharma management and operational teams to identify and advance business development opportunities for the company as part of its strategy to expand its pipeline.“I am delighted to welcome Aaron Schuchart to the Lumos Pharma management team,” said Rick Hawkins, Chairman, CEO and President. “Mr. Schuchart’s years of experience in business development and licensing for biotechnology companies large and small will lend further support to the company’s efforts to advance our strategy to expand its portfolio...

Continue reading

Osisko Mining – Notice of Annual Meeting of Shareholders

TORONTO, April 24, 2020 (GLOBE NEWSWIRE) — Osisko Mining Inc. (“Osisko” or the “Corporation”) (TSX: OSK) is pleased to announce that it has filed and commenced mailing of the notice of meeting and management information circular in connection with its annual meeting of shareholders (“the Meeting”) to be held on May 29, 2020 at 10:00 a.m. (Toronto time), at the offices of 155 University Avenue, Suite 1440, Toronto, Ontario, Canada, M5H 3B7.In view of the current health risks associated with large public gatherings, due to COVID-19, shareholders are asked to not attend the meeting in person, particularly if they are experiencing any of the described COVID-19 symptoms of fever, cough or difficulty breathing. Instead, shareholders will have an equal opportunity regardless of their geographic location to participate in the Meeting by...

Continue reading

Minière Osisko – Avis de convocation à l’assemblée annuelle des actionnaires

TORONTO, 24 avr. 2020 (GLOBE NEWSWIRE) — Minière Osisko inc. (« Osisko » ou la « Société ») (TSX : OSK) a le plaisir d’annoncer le dépôt et l’envoi par la poste de l’avis de convocation et de la circulaire de sollicitation de procurations en lien avec son assemblée annuelle des actionnaires (l’« assemblée ») qui aura lieu le 29 mai 2020 à 10 h 00 (heure de Toronto), aux bureaux sis au 155 University Avenue, bureau 1440, Toronto, Ontario, Canada, M5H 3B7.Compte tenu des risques sanitaires actuels associés aux grands rassemblements publics, en raison de la COVID-19, les actionnaires sont invités à ne pas se présenter à l’assemblée en personne, particulièrement s’ils présentent l’un ou l’autre des symptômes associés à la COVID-19, soit fièvre, toux ou difficultés respiratoires. En lieu et place, tous les actionnaires auront la possibilité...

Continue reading

Gentex Reports First Quarter 2020 Financial Results

ZEELAND, Mich., April 24, 2020 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass and fire protection technologies, today reported financial results for the three months ended March 31, 2020.1st Quarter 2020 SummaryNet Sales decline of 3% quarter over quarter versus a 24% quarter over quarter reduction in global light vehicle production volumesNovel coronavirus pandemic (COVID-19) negatively impacted first quarter net sales by approximately 9%Gross margin of 34.5% for the first quarter7.0 million shares repurchased during the quarterFor the first quarter of 2020, the Company reported net sales of $453.8 million, which was a decrease of 3% compared to net sales of $468.6 million in the first quarter of 2019. The impact of the COVID-19 pandemic created shutdowns...

Continue reading

MAYA Announces New President and CEO

MONTREAL, April 24, 2020 (GLOBE NEWSWIRE) — Maya Gold & Silver Inc. (“Maya” or the “Corporation”) (TSX: MYA) announces that Noureddine Mokaddem Chairman, President and Chief Executive Officer, is retiring and stepping down as Chairman, President and CEO of the Corporation. Mr. Mokaddem will remain on the Board of Directors of the Corporation. Concurrently, Mr. Benoit La Salle FCPA, CPA has been appointed by the Board of Directors as President and Chief Executive Officer and appointed as Director, effective immediately. In addition, Robert Taub has been appointed as Chairman of the Board of Maya.The board would like to take this opportunity to thank Mr. Mokaddem for his achievements with the Corporation since its early days and for advancing the Zgounder and Boumadine Projects. Mr. Mokaddem was instrumental in bringing the Corporation...

Continue reading

Daseke, Inc. to Release First Quarter 2020 Results on May 7, 2020

ADDISON, Texas, April 24, 2020 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North America, today announced that it plans to report results for its fiscal first quarter ended March 31, 2020 on May 7, 2020. A conference call to discuss the financial and operational results is scheduled for May 7, 2020 at 11:00 AM ET.Investors, analysts, and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides, available on the Company’s website at https://www.daseke.com. Interested parties may also participate in the call by dialing (855) 242-9918 and entering the passcode 9778049. A replay of the conference call will be available a few hours after...

Continue reading

Duluth Holdings, Inc. To Reconvene 2020 Annual Meeting of Shareholders to July 13, 2020 Due to COVID-19 Concerns

MOUNT HOREB, Wis., April 24, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced the Company plans to reconvene its 2020 Annual Meeting of Shareholders to July 13, 2020 to reflect public health concerns relating to the COVID-19 pandemic as well as recent government actions, including the ‘Safer at Home’ order extended until May 26, 2020 in the state of Wisconsin, where the Company is domiciled.In accordance with the Company’s bylaws and Wisconsin law, the Chairman of Duluth Trading intends to convene and immediately adjourn the Annual Meeting initially scheduled for May 21, 2020. There will be no further business conducted on May 21, 2020. The Chairman will then...

Continue reading

ORYZON to Initiate ESCAPE: a Phase II Clinical Trial to Test Efficacy of Vafidemstat in Severely ill COVID-19 Patients

CTA approval, the European IND equivalent, granted by the Spanish Drug Agency via an accelerated procedurePrimary endpoint: To investigate the efficacy of vafidemstat, in combination with standard of care treatment, to prevent Acute Respiratory Distress Syndrome (ARDS) in adult severely ill COVID-19 patientsMADRID, Spain and CAMBRIDGE, Mass., April 24, 2020 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that under certain urgency provisions related to the COVID-19 pandemic it has received approval from the Spanish Drug Agency (AEMPS) to conduct a Phase II clinical trial with vafidemstat in seriously ill COVID-19 patients.The study, named ESCAPE (Efficacy...

Continue reading

PAE-Perini Continues Support of U.S. Air Force with Spot on $6.4B AFCAP V Contract Vehicle

FALLS CHURCH, Va., April 24, 2020 (GLOBE NEWSWIRE) — PAE-Perini LLC was selected as one of eight awardees to support the U.S. Air Force on the seven-year Air Force Contract Augmentation Program V. With a ceiling value of $6.4 billion, the indefinite-delivery, indefinite-quantity contract vehicle prepares and executes the U.S. government for rapid responses to urgent mission needs around the world. PAE-Perini received the award after serving on the preceding contract vehicle, AFCAP IV.  PAE President and CEO John Heller said the award builds on previous successes of the joint venture between PAE (NASDAQ: PAE, PAEWW) and Perini Management Services, Inc. PAE-Perini fulfilled numerous task orders on AFCAP IV providing military bases with facility maintenance and design engineering services. The joint venture also supported airfield locations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.